首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
Elektromotor
摘要
申请公布号
DE50302489(D1)
申请公布日期
2006.04.27
申请号
DE20035002489
申请日期
2003.03.01
申请人
GEBHARDT VENTILATOREN GMBH & CO.
发明人
ANSCHUETZ, JOHANNES DR. ING.;PAUL, MATHIAS
分类号
H02K5/16;H02K1/30;H02K5/173
主分类号
H02K5/16
代理机构
代理人
主权项
地址
您可能感兴趣的专利
Use of sulfamide and glinide atp-sensitive potassium channel ligands for the preparation of pharmaceutical compositions for treating diabetes mellitus and/or neuropsychological disorders
Use of (9s,10s,12r)-10-hydroxy-10-hydroxymethyl-9-methyl-2,3,9,10,11,12-hexahydro-9,12-epoxy-1h-diindolo[1,2,3-fg:3',2',1'-kl] pyrrolo[3,4-i]-1,6-benzodiazocin-1-one for the manufacture of a medicament for treating myeloproliferative disorders associated with activation of jak2
METHOD AND APPARATUS FOR IMPROVING SERVICE QUALITY OF VIDEO CALL IN MOBILE COMMUNICATION SYSTEMS
SEMICONDUCTOR DEVICE PACKAGE
A TREATMENT SYSTEM OF LIQUEFIED GAS
Kaskadskrubber
B-cell reduction using CD37-specific and CD20-specific binding molecules
Method for treating senile cataract
Radiorepeterare
DIARYLHYDANTOIN COMPOUNDS AS ANDROGEN RECEPTOR ANTAGONISTS FOR TREATMENT OF CANCER
THREAD CYLINDER
PORTABLE SERVICE POINT
SIDE CURTAIN FOR A COMMERCIAL VEHICLE STRUCTURE
TREATMENT FOR INFECTION WITH HEPATITIS B VIRUS ALONE OR IN COMBINATION WITH HEPATITIS DELTA VIRUS AND ASSOCIATED LIVER DISEASES
METHYLPARABEN COCRYSTAL FORM A OF [4-(3-FLUORO-5-TRIFLUOROMETHYL-PYRIDIN-2-YL)-PIPERAZIN-L-YL]-[5-METHANESULFONYL-2- ((S) -2,2,2-TRIFLUORO- 1 -METHYL-ETHOXY) -PHENYL] -METHANONE
WATERMARK GENERATOR, WATERMARK DECODER, METHOD FOR PROVIDING A WATERMARK SIGNAL, METHOD FOR PROVIDING BINARY MESSAGE DATA IN DEPENDENCE ON A WATERMARKED SIGNAL AND A COMPUTER PROGRAM USING IMPROVED SYNCHRONIZATION CONCEPT
Anvendelse av 4-hydroksytamoxifen for fremstilling av et medikament for behandling av gynekomasti
METHOD FOR TRANSMITING DATA IN INDIRECT LINKS, METHOD FOR SELECTING RELAY IN INDIRECT LINKS COMMUNICATION SYSTEM AND SYSTEM FOR INDIRECT LINKS COMMUNICATION
ESTERS OF HEXANOIC ACIDS AS INTERMEDIATES FOR THE PREPARATION OF ATORVASTATIN
QUINOLINE AND QUINOXALINE DERIVATIVES AS KINASE INHIBITORS
